ANN ARBOR, Michigan – June 5, 2018 -  ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, has been awarded U.S. Patent Number 9,980,677 from the U.S. Patent and Trademark Office (“USPTO”) for a non-invasive...
Quarterly earnings season is the four times each year in which companies give investors an inside look as to what's going on. They not only reveal their sales and profits, but, typically, they provide guidance (either specifically or in...
Tailwinds' Take: data now expected in July should be positive. They need financing, but, once that is accomplished, this company will be poised for success. At current valuation, it's really discounting almost all possible success. ANN ARBOR, MI / May...
Shares of Endra (NDRA) have exchanged hands over 568,000 times today as I write this article. This compares to an average daily volume of around 7,000 shares traded. Needless to say, something sparked this movement; most likely a chat...
ANN ARBOR, MI / March 20, 2018 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, reported its financial and operational results for the fourth quarter and full year ended December 31, 2017. Key 2017 and Subsequent...
Tailwinds' Take: positive IP protection is going to position them well for inking a strategic investor in the next few months. ANN ARBOR, MI / February 15, 2018 / ENDRA Life Sciences Inc. ("ENDRA" or the "Company") (NASDAQ: NDRA), a developer of...
Tailwinds' Take: is it just us, or does anyone else think that GE makes perfect sense as a strategic investor in Endra, post the release of data in Q2?  ANN ARBOR, MI / February 5, 2018 / ENDRA Life Sciences Inc. ("ENDRA")...
As we enter the new year it is very difficult not to be optimistic...borderline exuberant. The Tailwinds Select Portfolio has been on a tear lately, closing the year with a bang. If gaining 20% in the last two months...
As 2017 winds down to a close, we have made several changes to the model portfolio. These changes are meant to better position our holdings for 2018. The changes are as follows: adding NDRA at an average weight of the...
ANN ARBOR, MI / ACCESSWIRE / November 15, 2017 / ENDRA Life Sciences Inc.("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, reported its financial and operational results for the third quarter ended September 30, 2017. Key Third Quarter 2017 and...